AJ

Alpa Jatin Vaghela

Active Director Director DIN 08583036
DIN 08583036 First appointment Oct 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Alpa Jatin Vaghela

Data last updated:

Alpa Jatin Vaghela is a Director at Sushen Pharma Care Private Limited (since 2019). The company operates in Pharma.

DIN 08583036
Primary Designation Director
Industry Pharma
First Appointment 10 Oct 2019
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sushen Pharma Care Private Limited U24230GJ2011PTC063998
Director10 Oct 20192011Active

Directorship timeline

Open interactive timeline →
Sushen Pharma Care Private Limited
Premium access

Shareholding and investment profile for Alpa Jatin Vaghela

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alpa Jatin Vaghela

Alpa Jatin Vaghela currently holds 1 directorship: Sushen Pharma Care Private Limited (Director, since 10 Oct 2019).

Alpa Jatin Vaghela was first appointed on 10 Oct 2019 as Director at Sushen Pharma Care Private Limited.

The current boards of Alpa Jatin Vaghela's companies include Chunilal Gopaldas Vaghela (Sushen Pharma Care Private Limited), Niraj Chunibhai Vaghela (Sushen Pharma Care Private Limited), Riddhi Hrinbhai Vaghela (Sushen Pharma Care Private Limited), Sonal Niraj Vaghela (Sushen Pharma Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available